Depression and Anxiety Trial, Recruiting NCT07145307 Sponsor: Helse Stavanger HF Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07145307
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 13 and 18 years old
  • People who can read, write, and speak Norwegian well enough to take part
  • People who have access to the internet and a smartphone
  • People who have been diagnosed with an anxiety disorder
  • People who are currently receiving outpatient treatment (treatment without being admitted to hospital) for their anxiety disorder
  • People whose treatment during the study period includes a type of therapy called exposure therapy, where a person gradually faces things that cause anxiety
  • People whose therapist agrees to use the trial app as an add-on to their regular therapy sessions
  • People who are taking medication for a mental health condition must have been on a stable dose of that medication for at least six weeks before joining

Who may not be able to join:

  • People with serious mental health concerns — such as thoughts of suicide or very poor day-to-day functioning — may not be able to take part if the trial site determines that joining could be unsafe or unworkable. This decision would be made together by the person's therapist and the research team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aleksander H Erga, PhD, KORFOR, Helse Stavanger

Phone: +47 92877830

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Helse Stavanger HF
Registry
ClinicalTrials.gov
Start date
20 October 2025
Est. completion
1 October 2026

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Sidekick app engagement and completion of tasks; Credibility and Expectancy Questionnaire (CEQ-1); Client Satisfaction Questionnaire (CSQ-3); EuroQoL 5D-5L (EQ-5D-5L); Level of anxiety before, during and after exposure tasks; Recruitment; Adherence; Qualitative interviews; Revised Child Anxiety and Depression Scale (RCADS 47); General self-efficacy scale (GSES); KIDSCREEN-10; Patient Exposure and Response Prevention Adherence Scale (PEAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov